Effects of Cirrhosis and Diagnosis Scenario in Metabolic‐Associated Fatty Liver Disease‐Related Hepatocellular Carcinoma-Reference-Cited by-同舟云学术

Effects of Cirrhosis and Diagnosis Scenario in Metabolic‐Associated Fatty Liver Disease‐Related Hepatocellular Carcinoma

Published:2020-09-24 Issue:1 Volume:5 Page:122-132
ISSN:2471-254X
Container-title:Hepatology Communications
language:en
Short-container-title:Hepatol. Commun.

Author:

Chen Vincent L.¹^ORCID,Yeh Ming‐Lun²³⁴,Yang Ju Dong⁵,Leong Jennifer⁶,Huang Daniel Q.⁷⁸,Toyoda Hidenori⁹,Chen Yao‐Li¹⁰,Guy Jennifer¹¹,Maeda Mayumi¹²,Tsai Pei‐Chien²³⁴,Huang Chung‐Feng²³⁴^ORCID,Yasuda Satoshi⁹,Le An K.¹²,Dang Hansen¹²,Giama Nasra H.¹³,Ali Hamdi A.¹³,Zhang Ning¹³,Wang Xiaozhong¹⁴,Jun Dae Won¹⁵^ORCID,Tseng Cheng‐Hao¹⁶,Hsu Yao‐Chun¹⁶,Huang Jee‐Fu²³⁴,Dai Chia‐Yen²³⁴,Chuang Wan‐Long²³⁴,Zhu Qiang¹⁷,Dan Yock Young⁷⁸,Schwartz Myron⁶,Roberts Lewis R.⁵,Yu Ming‐Lung²³⁴^ORCID,Nguyen Mindie H.¹²^ORCID

Affiliation:

1. Division of Gastroenterology University of Michigan Health System Ann Arbor MIUSA

2. Hepatobiliary Division Kaohsiung Medical University Hospital Kaohsiung Taiwan

3. Hepatitis Research Center College of Medicine Kaohsiung Medical University Kaohsiung Taiwan

4. Center for Cancer Research Kaohsiung Medical University Kaohsiung Taiwan

5. Comprehensive Transplant Center Cedars Sinai Medical Center Los Angeles CAUSA

6. Division of Liver Diseases Recanati/Miller Transplantation InstituteIcahn School of Medicine New York NYUSA

7. Division of Gastroenterology and Hepatology Department of Medicine National University Health System Singapore Singapore

8. Department of Medicine National University of Singapore Singapore Singapore

9. Department of Gastroenterology Ogaki Municipal Hospital Ogaki Japan

10. Department of Surgery Changhua Christian Hospital Changhua Taiwan

11. Division of Gastroenterology and Hepatology California Pacific Medical Center San Francisco CA

12. Division of Gastroenterology and Hepatology Stanford University Medical Center Stanford CA

13. Department of Gastroenterology and Hepatology Mayo Clinic Rochester MN

14. Division of Gastroenterology and Hepatology Traditional Chinese Medicine Hospital of Xinjiang Uyghur Autonomous Region Urumqi China

15. Division of Gastroenterology Hanyang University Medical Center Seoul Republic of Korea

16. Division of Gastroenterology and Hepatology E‐Da Cancer Hospital/I‐Shou University Kaohsiung Taiwan

17. Division of Gastroenterology and Hepatology Shandong Provincial Hospital Affiliated to Shandong University Jinan China

Funder

Kaohsiung Medical University

National Cancer Institute

National Institute of Diabetes and Digestive and Kidney Diseases

Agency for Science, Technology and Research

National Natural Science Foundation of China

Publisher

Wiley

Subject

General Medicine

Link

https://onlinelibrary.wiley.com/doi/pdf/10.1002/hep4.1606

Reference45 articles.

1. Epidemiology and surveillance for hepatocellular carcinoma: New trends

2. MAFLD: A Consensus-Driven Proposed Nomenclature for Metabolic Associated Fatty Liver Disease

3. A new definition for metabolic dysfunction-associated fatty liver disease: An international expert consensus statement

4. Projections of primary liver cancer to 2030 in 30 countries worldwide

Cited by 18 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Cost-Effectiveness Analysis of Hepatocellular Carcinoma Surveillance in Nonalcoholic Fatty Liver Disease Cirrhosis Using US Visualization Score C–Triggered Abbreviated MRI;American Journal of Gastroenterology;2024-02-05

2. MAFLD: an optimal framework for understanding liver cancer phenotypes;Journal of Gastroenterology;2023-07-20

3. Association Between Sensitivity to Thyroid Hormones and Metabolic Dysfunction-Associated Fatty Liver Disease in Euthyroid Subjects: A Cross-Sectional Study;Diabetes, Metabolic Syndrome and Obesity;2023-07

4. Clinicopathological Features of Hepatocellular Carcinoma with Metabolic Risk Factors;Journal of Hepatocellular Carcinoma;2023-06

5. Stationary Trend in Elevated Serum Alpha-Fetoprotein Level in Hepatocellular Carcinoma Patients;Cancers;2023-02-15